FindTrial
Sign In

To Compare changes in diaphragmatic function after USG guided Intermediate cervical plexus bock using 10ml 0.3 percent ropivacaine versus 10ml 0.5 percent ropivacaine in cases of upper limb surgeries under USG guided Supraclavicular brachial plexus block.

A Randomized Comparative study for evaluation of diaphragmatic function after USG guided Intermediate cervical plexus bock 10ml of 0.3 percent versus 10ml of 0.5 percent ropivacaine in cases of upper limb surgeries under USG guided Supraclavicular brachial plexus block at SMS medical college, Jaipur - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100530
Enrollment
100
Registered
2026-01-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S422- Fracture of upper end of humerus Health Condition 2: S423- Fracture of shaft of humerus

Interventions

Intervention1: 10ml 0f 0.5% ropivacaine for intermediate cervical plexus block: We will evaluate whether USG guided U/L intermediate cervical plexus block with different concentrations of ropivacaine(

Sponsors

Sawai Man Singh medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients undergoing upper limb surgery. 2. Adult patients aged 18-65 years of both sexes. 3. Patients belonging to American Society of Anaesthesiologists (ASA) physical status I, II and III. 4. Patients giving consent for participation.

Exclusion criteria

Exclusion criteria: 1. Patient should not be part of any other study. 2. History of allergy to local anaesthetics and Iohexol dye. 3. Patients on anticoagulant therapy and/or history of coagulation disorders. 4. Local infection at the proposed site of intermediate cervical plexus block or supraclavicular brachial plexus block. 5. Patients with respiratory illness/compromise. 6. Patients with existing sensorineural deficit in the upper limb to be operated. 7. Patients not able to report assessment of block.

Design outcomes

Primary

MeasureTime frame
Mean change in diaphragmatic excursion and thickness from the baseline.Timepoint: Mean change in diaphragmatic excursion and thickness from the baseline at 40 minutes after ICPB.—

Secondary

MeasureTime frame
1) Change in diaphragmatic excursion after SCBP block 2) Change in diaphragmatic thickness after SCBP blockTimepoint: 1) Change in diaphragmatic excursion after 40 minutes of SCBP block 2) Change in diaphragmatic thickness after 40 minutes of SCBP block—

Countries

India

Contacts

Public ContactDr Rashmitha N

Sawai Man Singh medical college, Jaipur

vandanamangal25@gmail.com9829056816

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026